Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $BMY vs $CORT | Chartloom

Compare

$BMY vs $CORT

Bristol-Myers Squibb Co · Corcept Therapeutics Inc

BMY

Bristol-Myers Squibb Co

CORT

Corcept Therapeutics Inc

Compare $BMY vs $CORT

Comparing Bristol-Myers Squibb Co and Corcept Therapeutics Inc

BMYBristol-Myers Squibb Co

CORTCorcept Therapeutics Inc

BMYBristol-Myers Squibb Co

Market cap

$115.72B

P/E (TTM)

12.50x

Forward P/E (NTM)

8.72x

Forward P/S (NTM)

2.37x

Rev growth (TTM)

38.5%

YTD performance

6.0%

52W performance

28.9%

FCF yield

14.4%

CORTCorcept Therapeutics Inc

Market cap

$12.73B

P/E (TTM)

252.72x

Forward P/E (NTM)

28.94x

Forward P/S (NTM)

8.27x

Rev growth (TTM)

16.0%

YTD performance

208.4%

52W performance

59.3%

FCF yield

0.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BMY

CORT

Detailed metrics comparison

BMY

Bristol-Myers Squibb Co

CORT

Corcept Therapeutics Inc

Market Cap

BMY$115.72B

CORT$12.73B

Enterprise Value

BMY$150.12B

CORT$12.62B

Price

BMY$56.67

CORT$117.80

P/E Ratio

BMY12.50x

CORT252.72x

P/S Ratio

BMY2.35x

CORT15.33x

EV/Sales

BMY3.05x

CORT15.19x

EV/EBITDA

BMY6.41x

CORT1,442.80x

P/B Ratio

BMY5.41x

CORT18.56x

P/FCF Ratio

BMY6.93x

CORT119.10x

EV/FCF

BMY9.00x

CORT118.06x

PEG Ratio

BMYN/A

CORTN/A

Forward P/E (NTM)

BMY8.72x

CORT28.94x

Forward P/S (NTM)

BMY2.37x

CORT8.27x

Revenue (TTM)

BMY$49.19B

CORT$831M

Revenue Growth (YoY)

BMY38.5%

CORT16.0%

Forward Rev Growth

BMY-3.1%

CORT48.8%

Gross Margin (TTM)

BMY71.7%

CORT98.3%

Operating Margin (TTM)

BMY25.5%

CORT0.8%

EBITDA Margin (TTM)

BMY46.1%

CORT1.0%

Net Margin (TTM)

BMY18.9%

CORT6.6%

FCF Margin (TTM)

BMY33.9%

CORT12.9%

Net Income (TTM)

BMY$9.28B

CORT$55M

FCF (TTM)

BMY$16.69B

CORT$107M

EPS (TTM)

BMY$4.53

CORT$0.47

ROE (TTM)

BMY46.8%

CORT8.4%

ROA (TTM)

BMY10.3%

CORT6.6%

ROIC (TTM)

BMY14.2%

CORT8.4%

Cash

BMY$8.72B

CORT$111M

Debt

BMY$43.12B

CORT$0

Net Cash/Debt

BMY$-34.40B

CORT$111M

Current Ratio (TTM)

BMY1.53x

CORT2.86x

Quick Ratio (TTM)

BMY1.39x

CORT2.63x

Debt/Equity (TTM)

BMY1.93x

CORT0.00x

Debt/Assets (TTM)

BMY0.0%

CORT0.0%

Interest Coverage (TTM)

BMYN/A

CORTN/A

Net Debt/EBITDA (TTM)

BMY0.00x

CORT0.00x

Beta

BMY0.18

CORT0.52

52W Performance

BMY28.9%

CORT59.3%

YTD Performance

BMY6.0%

CORT208.4%

% from 52W High

BMY-17.4%

CORT-6.8%

% from 52W Low

BMY33.3%

CORT311.0%

Asset Turnover (TTM)

BMY0.54x

CORT0.99x

FCF Yield (TTM)

BMY14.4%

CORT0.8%

Earnings Yield (TTM)

BMY8.0%

CORT0.4%

Dividend Yield (TTM)

BMY6.3%

CORTN/A

Rule of 40

BMY72.5

CORT28.9

EV/GP/RG

BMYN/A

CORT0.18

Ticker research

View BMY research View CORT research

Metric	BMY Bristol-Myers Squibb Co	CORT Corcept Therapeutics Inc
Market & Valuation
Market Cap	$115.72B	$12.73B
Enterprise Value	$150.12B	$12.62B
Price	$56.67	$117.80
P/E Ratio	12.50x	252.72x
P/S Ratio	2.35x	15.33x
EV/Sales	3.05x	15.19x
EV/EBITDA	6.41x	1,442.80x
P/B Ratio	5.41x	18.56x
P/FCF Ratio	6.93x	119.10x
EV/FCF	9.00x	118.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	8.72x	28.94x
Forward P/S (NTM)	2.37x	8.27x
Revenue & Growth
Revenue (TTM)	$49.19B	$831M
Revenue Growth (YoY)	38.5%	16.0%
Forward Rev Growth	-3.1%	48.8%
Profitability
Gross Margin (TTM)	71.7%	98.3%
Operating Margin (TTM)	25.5%	0.8%
EBITDA Margin (TTM)	46.1%	1.0%
Net Margin (TTM)	18.9%	6.6%
FCF Margin (TTM)	33.9%	12.9%
Net Income (TTM)	$9.28B	$55M
FCF (TTM)	$16.69B	$107M
EPS (TTM)	$4.53	$0.47
ROE (TTM)	46.8%	8.4%
ROA (TTM)	10.3%	6.6%
ROIC (TTM)	14.2%	8.4%
Financial Health
Cash	$8.72B	$111M
Debt	$43.12B	$0
Net Cash/Debt	$-34.40B	$111M
Current Ratio (TTM)	1.53x	2.86x
Quick Ratio (TTM)	1.39x	2.63x
Debt/Equity (TTM)	1.93x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.18	0.52
52W Performance	28.9%	59.3%
YTD Performance	6.0%	208.4%
% from 52W High	-17.4%	-6.8%
% from 52W Low	33.3%	311.0%
Efficiency & Yields
Asset Turnover (TTM)	0.54x	0.99x
FCF Yield (TTM)	14.4%	0.8%
Earnings Yield (TTM)	8.0%	0.4%
Dividend Yield (TTM)	6.3%	N/A
Other
Rule of 40	72.5	28.9
EV/GP/RG	N/A	0.18
Ticker research	View BMY research	View CORT research

Valuation

P/E Ratio

BMY

12.50x

CORT

252.72x

P/S Ratio

BMY

2.35x

CORT

15.33x

EV/FCF

BMY

9.00x

CORT

118.06x

Growth & revenue

Revenue Growth TTM

BMY

38.5%

CORT

16.0%

Forward Revenue Growth

CORT

48.8%

BMY

-3.1%

Profitability & performance

Gross Margin

CORT

98.3%

BMY

71.7%

ROE

BMY

46.8%

CORT

8.4%

FCF Yield %

BMY

14.4%

CORT

0.8%

52-Week Performance

CORT

59.3%

BMY

28.9%

Detailed metrics comparison

BMY

Bristol-Myers Squibb Co

CORT

Corcept Therapeutics Inc

Market Cap

BMY$115.72B

CORT$12.73B

Enterprise Value

BMY$150.12B

CORT$12.62B

Price

BMY$56.67

CORT$117.80

P/E Ratio

BMY12.50x

CORT252.72x

P/S Ratio

BMY2.35x

CORT15.33x

EV/Sales

BMY3.05x

CORT15.19x

EV/EBITDA

BMY6.41x

CORT1,442.80x

P/B Ratio

BMY5.41x

CORT18.56x

P/FCF Ratio

BMY6.93x

CORT119.10x

EV/FCF

BMY9.00x

CORT118.06x

PEG Ratio

BMYN/A

CORTN/A

Forward P/E (NTM)

BMY8.72x

CORT28.94x

Forward P/S (NTM)

BMY2.37x

CORT8.27x

Revenue (TTM)

BMY$49.19B

CORT$831M

Revenue Growth (YoY)

BMY38.5%

CORT16.0%

Forward Rev Growth

BMY-3.1%

CORT48.8%

Gross Margin (TTM)

BMY71.7%

CORT98.3%

Operating Margin (TTM)

BMY25.5%

CORT0.8%

EBITDA Margin (TTM)

BMY46.1%

CORT1.0%

Net Margin (TTM)

BMY18.9%

CORT6.6%

FCF Margin (TTM)

BMY33.9%

CORT12.9%

Net Income (TTM)

BMY$9.28B

CORT$55M

FCF (TTM)

BMY$16.69B

CORT$107M

EPS (TTM)

BMY$4.53

CORT$0.47

ROE (TTM)

BMY46.8%

CORT8.4%

ROA (TTM)

BMY10.3%

CORT6.6%

ROIC (TTM)

BMY14.2%

CORT8.4%

Cash

BMY$8.72B

CORT$111M

Debt

BMY$43.12B

CORT$0

Net Cash/Debt

BMY$-34.40B

CORT$111M

Current Ratio (TTM)

BMY1.53x

CORT2.86x

Quick Ratio (TTM)

BMY1.39x

CORT2.63x

Debt/Equity (TTM)

BMY1.93x

CORT0.00x

Debt/Assets (TTM)

BMY0.0%

CORT0.0%

Interest Coverage (TTM)

BMYN/A

CORTN/A

Net Debt/EBITDA (TTM)

BMY0.00x

CORT0.00x

Beta

BMY0.18

CORT0.52

52W Performance

BMY28.9%

CORT59.3%

YTD Performance

BMY6.0%

CORT208.4%

% from 52W High

BMY-17.4%

CORT-6.8%

% from 52W Low

BMY33.3%

CORT311.0%

Asset Turnover (TTM)

BMY0.54x

CORT0.99x

FCF Yield (TTM)

BMY14.4%

CORT0.8%

Earnings Yield (TTM)

BMY8.0%

CORT0.4%

Dividend Yield (TTM)

BMY6.3%

CORTN/A

Rule of 40

BMY72.5

CORT28.9

EV/GP/RG

BMYN/A

CORT0.18

Ticker research

View BMY research View CORT research

Metric	BMY Bristol-Myers Squibb Co	CORT Corcept Therapeutics Inc
Market & Valuation
Market Cap	$115.72B	$12.73B
Enterprise Value	$150.12B	$12.62B
Price	$56.67	$117.80
P/E Ratio	12.50x	252.72x
P/S Ratio	2.35x	15.33x
EV/Sales	3.05x	15.19x
EV/EBITDA	6.41x	1,442.80x
P/B Ratio	5.41x	18.56x
P/FCF Ratio	6.93x	119.10x
EV/FCF	9.00x	118.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	8.72x	28.94x
Forward P/S (NTM)	2.37x	8.27x
Revenue & Growth
Revenue (TTM)	$49.19B	$831M
Revenue Growth (YoY)	38.5%	16.0%
Forward Rev Growth	-3.1%	48.8%
Profitability
Gross Margin (TTM)	71.7%	98.3%
Operating Margin (TTM)	25.5%	0.8%
EBITDA Margin (TTM)	46.1%	1.0%
Net Margin (TTM)	18.9%	6.6%
FCF Margin (TTM)	33.9%	12.9%
Net Income (TTM)	$9.28B	$55M
FCF (TTM)	$16.69B	$107M
EPS (TTM)	$4.53	$0.47
ROE (TTM)	46.8%	8.4%
ROA (TTM)	10.3%	6.6%
ROIC (TTM)	14.2%	8.4%
Financial Health
Cash	$8.72B	$111M
Debt	$43.12B	$0
Net Cash/Debt	$-34.40B	$111M
Current Ratio (TTM)	1.53x	2.86x
Quick Ratio (TTM)	1.39x	2.63x
Debt/Equity (TTM)	1.93x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.18	0.52
52W Performance	28.9%	59.3%
YTD Performance	6.0%	208.4%
% from 52W High	-17.4%	-6.8%
% from 52W Low	33.3%	311.0%
Efficiency & Yields
Asset Turnover (TTM)	0.54x	0.99x
FCF Yield (TTM)	14.4%	0.8%
Earnings Yield (TTM)	8.0%	0.4%
Dividend Yield (TTM)	6.3%	N/A
Other
Rule of 40	72.5	28.9
EV/GP/RG	N/A	0.18
Ticker research	View BMY research	View CORT research